by The global pharmaceutical unit-dose packaging market size was estimated to be around US$ 35.40 billion in 2023 and is projected to reach US$ 141.36 billion by 2033, indicating a CAGR of 14.85% from 2024 to 2033.
Key Points
- North America held the largest market share of 34% in 2023.
- Asia Pacific is observed to witness the fastest rate of expansion during the forecast period.
- By material, the plastic segment dominated the market with the highest revenue share of 48% in 2023.
- By material, the glass material segment holds a significant share of the market.
- By product type, the vials segment has captured the largest market share of 30% in 2023.
- By product type, the blisters segment is observed to witness the fastest rate of expansion during the forecast period.
- By end-use, the oral segment dominated the market in 2023.
The market research report on the pharmaceutical unit-dose packaging market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of pharmaceutical unit-dose packaging products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3896
Pharmaceutical Unit-dose Packaging Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 14.85% |
| Global Market Size in 2023 | USD 35.40 Billion |
| Global Market Size by 2033 | USD 141.36 Billion |
| U.S. Market Size in 2023 | USD 8.43 Billion |
| U.S. Market Size by 2033 | USD 33.64 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Material, By Product, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: IT Devices Market Size to Rise USD 4,436.53 Bn by 2033
The report presents the volume and value-based market size for the base year 2023 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global pharmaceutical unit-dose packaging market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the pharmaceutical unit-dose packaging market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of pharmaceutical unit-dose packaging products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2024 to 2033. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the pharmaceutical unit-dose packaging market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the pharmaceutical unit-dose packaging market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Pharmaceutical Unit-dose Packaging Market Companies
- Pfizer Inc
- Bristol-Myers Squibb Company
- Merck & Co. Inc.
- AbbVie Inc.
- Gerresheimer AG
- Comar LLC
- Amcor Plc.
- Johnson & Johnson
- UDG Healthcare Plc
- Berry Global, Inc.
Segments Covered in the Report
By Material
- Plastics
- Glass
- Paper and Paperboard
- Metal
By Product
- Vials
- Syringe and cartridge
- Ampoules
- Blisters
By End-use
- Ophthalmic
- Injectable
- Biologics
- Wound Care
- Respiratory Therapy
- Orals
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Unit-dose Packaging Market
5.1. COVID-19 Landscape: Pharmaceutical Unit-dose Packaging Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Unit-dose Packaging Market, By Material
8.1. Pharmaceutical Unit-dose Packaging Market Revenue and Volume, by Material, 2024-2033
8.1.1 Plastics
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Glass
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Paper and Paperboard
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Metal
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Pharmaceutical Unit-dose Packaging Market, By Product
9.1. Pharmaceutical Unit-dose Packaging Market Revenue and Volume, by Product, 2024-2033
9.1.1. Vials
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Syringe and Cartridge
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Ampoules
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Blisters
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Pharmaceutical Unit-dose Packaging Market, By End-use
10.1. Pharmaceutical Unit-dose Packaging Market Revenue and Volume, by End-use, 2024-2033
10.1.1. Ophthalmic
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Injectable
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Biologics
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Wound Care
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Respiratory Therapy
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Pharmaceutical Unit-dose Packaging Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 12. Company Profiles
12.1. Pfizer Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bristol-Myers Squibb Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck & Co. Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AbbVie Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Gerresheimer AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Comar LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Amcor Plc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Johnson & Johnson
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. UDG Healthcare Plc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Berry Global, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
